Biologics

Spinal Implants

Xtant Medical Announces First Quarter 2022 Financial Results

BELGRADE, Mont. , May 05, 2022 (GLOBE NEWSWIRE) — Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today reported financial and operating results for the first quarter ended March 31, 2022 .